AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped ...

Fortrea Holdings Inc.’s FTRE share price has surged by 5.64%, which has investors questioning if this is right time to sell.

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

LEXINGTON, KENTUCKY / ACCESS Newswire / April 24, 2025 / Today, NX Development Corp ("NXDC"), a Lexington, KY based life sciences company, announced the return of the sales and marketing rights for ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

Aquestive Therapeutics, Inc.’s AQST share price has surged by 6.91%, which has investors questioning if this is right time to sell.

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

Nijmegen, Netherlands Wednesday, April 23, 2025, 13:00 Hrs [IST] ...